RJA
LLY icon

Ross\Johnson & Associates’s Eli Lilly LLY Stock Holding History

Ross\Johnson & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Hold
17
– – 0.32% 28
2026
Q1 		$15.6K Hold
17
– – 0.28% 31
2025
Q4 		$18.3K Sell
17
-1
-6% -$956 0.34% 29
2025
Q3 		$13.7K Hold
18
– – 0.26% 29
2025
Q2 		$14K Hold
18
– – 0.29% 27
2025
Q1 		$14.9K Buy
18
+1
+6% +$832 0.26% 43
2024
Q4 		$13.1K Buy
+17
New +$14.1K 0.3% 27

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ross\Johnson & Associates's LLY Position: Q2 2026 in Review

Ross\Johnson & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 17 shares worth $20.4K. The position accounts for 0.32% of the portfolio, ranked #28.

Ross\Johnson & Associates first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ross\Johnson & Associates held 17 shares of Eli Lilly worth $20.4K as of Q2 2026.
  • Ross\Johnson & Associates left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.32% of Ross\Johnson & Associates's portfolio in Q2 2026, its #28 holding.
  • Ross\Johnson & Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.